Manufacturer
BAYER HEALTHCARE LLC,
Contents
Antihemophilic factor VIII (recombinant)
Indication
Treatment and prophylaxis of haemorrhagic episodes in patients with haemophilia A and Prophylaxis in severe haemophilia A
Instruction
Administer via Intravenous If refrigerated, warm dried concentrate and diluent to room temperature before reconstitution.
Drug interaction
Not known
Malaysia
